Susquehanna International Group, LLP PROGENICS PHARMACEUTICALS IN Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
N/A
-65,909 Closed
0 $0
Q1 2020

May 15, 2020
BUY
N/A
16,961 Added 34.65%
65,909 $250,000
Q4 2019

Feb 14, 2020
SELL
N/A
-45,646 Reduced 48.25%
48,948 $249,000
Q3 2019

Nov 14, 2019
SELL
N/A
-55,859 Reduced 37.13%
94,594 $478,000
Q2 2019

Aug 16, 2019
BUY
N/A
11,505 Added 8.28%
150,453 $928,000
Q2 2019

Aug 14, 2019
SELL
N/A
-205,026 Reduced 59.61%
138,948 $857,000
Q4 2018

Feb 14, 2019
BUY
N/A
107,007 Added 45.16%
343,974 $1.45 Million
Q3 2018

Nov 14, 2018
SELL
N/A
-10,024 Reduced 4.06%
236,967 $1.49 Million
Q2 2018

Aug 14, 2018
SELL
N/A
-140,593 Reduced 36.27%
246,991 $1.99 Million
Q1 2018

May 15, 2018
BUY
N/A
162,883 Added 72.49%
387,584 $2.89 Million
Q4 2017

Feb 14, 2018
BUY
N/A
102,322 Added 83.61%
224,701 $1.34 Million
Q3 2017

Nov 14, 2017
BUY
N/A
122,379
122,379 $901,000
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email